Leaderboard

En | De
No articles selected!     View Cart  
You are here: Neurology » Alzheimer 23. March 2026
Search
medline.ch
Alzheimer
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 3483  Previews Next
   
   Articles 1 - 20 / 69641  
   
Deep learning for FDG-PET classification in patients with Alzheimer's disease, dementia with Lewy bodies and their mixed pathology: a solution for diagnostic heterogeneity.
Front Aging Neurosci
Kim S, Jeon S, Cho K, Kang S, Bang S, Ye BS, Lee JM.
PMID: 41868427 [PubMed]


Zebrafish study provides evidence for Porphyromonas gingivalis outer membrane vesicles eliciting Alzheimer's disease-like pathologies.
Front Cell Infect Microbiol
Guo J, Lin K, Liang R, Jiang L, He X, Chen J, Zheng M.
PMID: 41868145 [PubMed - indexed for MEDLINE]


5xFAD-NSG mice: a preclinical Alzheimer model for human cell therapy studies.
bioRxiv
Graber DJ, Sentman ML, Cook WJ, Sentman CL.
PMID: 41867873 [PubMed]


Artificial neural networks fighting real neural decline: a systematic review of AI in Alzheimer's research.
Artif Intell Rev
Mou FS, Ahmed T, Huda MN, Nandi AK.
PMID: 41867506 [PubMed]


Streamlining Eligibility Assessment for Alzheimer's Disease-Modifying Therapies: Prediction of MMSE Scores Using the Digital Clock and Recall.
medRxiv
Jannati A, Toro-Serey C, Ciesla M, Chen E, Showalter J, Bates D, Pascual-Leone A, Tobyne S.
PMID: 41867219 [PubMed]


Effects of a 24-week resistance exercise program on brain amyloid and Alzheimer's disease blood-based biomarkers: the AGUEDA randomized controlled trial.
medRxiv
Solis-Urra P, Olvera-Rojas M, García-Rivero Y, Zeng X, Chen Y, Sehrawat A, Shekari M, Oberlin LE, Erickson KI, Karikari TK, Gómez-Río M, Ortega FB, Esteban-Cornejo I.
PMID: 41867189 [PubMed]


Can we refute a role for infections in Alzheimer's disease pathogenesis?
Alzheimers Dement
Chatila ZK, Duggan MR, Silberberg E, Fernandez J, Auber LA, Bradshaw EM, Schultek NM.
PMID: 41867029 [PubMed - indexed for MEDLINE]


From autopsy to PET to cerebrospinal fluid to blood: Quantifying reference-standard dependence in Alzheimer's disease amyloid biomarker validation.
J Alzheimers Dis
Verma K, Kumar S.
PMID: 41866791 [PubMed - as supplied by publisher]


Is Alzheimer's an Autoimmune Disease?
Mol Neurobiol
Corrada BR, Speth RC.
PMID: 41866640 [PubMed - indexed for MEDLINE]


Molecular mechanisms of exercise-induced improvements in Alzheimer's disease: a focus on lipid homeostasis.
Transl Neurodegener
Zhou J, Zhang X, Yin S, Xue S, He Q, Chen S, Xue X.
PMID: 41866584 [PubMed - indexed for MEDLINE]


Sensitivity comparison of longitudinal cognitive function indicators of Alzheimer's disease after mild cognitive impairment: a prospective cohort study.
Sci Rep
Guo G, Song W, Wang A, Cui Q, Yang X, Wang Y, Ma Y, Han H, Li Z, Zhang Z, Meng W, Wang S, Shi F.
PMID: 41866365 [PubMed - as supplied by publisher]


Population and single-cell analyses reveal immune cell-specific expression profiles associated with Alzheimer's disease risk.
Alzheimers Dement
Lindbohm JV, Stra, Lee HM, Ashenberg O, Mars N, Sipilä PN, Ripatti S, Graham D, Kivimäki M, Xavier RJ.
PMID: 41866337 [PubMed - indexed for MEDLINE]


Targeting of the PI3K/AKT/mTOR signaling pathway in the neurovascular interface in both Alzheimer's disease and atherosclerosis: The potential nexus.
Microvasc Res
Alameen AAM, Al-Kuraishy HM, Al-Gareeb AI, Shokr MM, Batiha GE.
PMID: 41865874 [PubMed - as supplied by publisher]


Therapeutic efficacy of engineered exosomes in Alzheimer's disease: A systematic review and meta-analysis of preclinical animal models.
Neuroscience
Li A, Peng W, Wu B, Li C, Yang J.
PMID: 41865827 [PubMed - as supplied by publisher]


Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimer's disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials.
Lancet
Cummings JL, Atri A, Sano M, Zetterberg H, Scheltens P, Knop FK, Johannsen P, Wichmann CA, Abschneider RM, Leon T, Feldman HH.
PMID: 41865758 [PubMed - as supplied by publisher]


Nanomaterials for Alzheimer's disease: emerging strategies in diagnosis and therapy.
J Nanobiotechnology
Na Y, Bai J, Zhang N, Geng F, Wang X.
PMID: 41864895 [PubMed - as supplied by publisher]


Epidemiological burden of Alzheimer's and Parkinson's diseases in East Asia: A comparative review of global burden of disease estimates and national registry data.
J Formos Med Assoc
Fan SP, Liu PC, Wang JZ, Win NN, Lin CH, Lin HH.
PMID: 41864794 [PubMed - as supplied by publisher]


Spirituality, culture, and family resilience in Alzheimer's care: A qualitative descriptive study in Türkiye.
Arch Psychiatr Nurs
Erkay, Çelik D.
PMID: 41864723 [PubMed - indexed for MEDLINE]


Transcranial Ultrasound Stimulation and Vagus Nerve Stimulation: Potential Therapeutic Strategies for Alzheimer's Disease.
Brain Res Bull
Wang B, Cheng K, Chen Z, Chen Y, Wang Z, Ni J.
PMID: 41864514 [PubMed - as supplied by publisher]


PANoptosis in Alzheimer's disease: The expanding landscape of programmed cell death mechanisms and therapeutic interventions.
Free Radic Biol Med
Paidlewar M, Kumari S, Dhapola R, Sharma P, Vellingiri B, Medhi B, HariKrishnaReddy D.
PMID: 41864364 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 69641    Page 1 of 3483  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1